KRAS and cancer: Therefore, a thorough understanding of the mechanisms of the proinflammatory state in conjunction with cancer-related gene aberrations may provide a scientific rationale to develop effective therapeutic strategies for advanced KRAS+/TP53+ mutant cancer.